Astonea Labs Ltd IPO

About Astonea Labs Ltd

Our Company was originally incorporated as AHU Laboratories Private Limited, as a private limited company, under the provisions of the Companies Act, 2013 pursuant to certificate of incorporation dated April 11, 2017. Our Company changed its name from AHU Laboratories Private Limited to Astonea Labs Private Limited pursuant to Rule 29 of the Companies (Incorporation) Rules, 2014 vide certificate of incorporation dated February 26, 2019. Subsequently, our Company converted into Astonea Labs Limited, a public limited company vide fresh certificate of incorporation dated January 11, 2024 the Corporate Identification Number of our Company is U24304CH2017PLC041482.

India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications. The Indian Pharmaceutical industry is currently ranked third in pharmaceutical production by volume after evolving over time into a thriving industry growing at a CAGR of 9.43% since the past nine years. Generic drugs, over-the-counter medications, bulk drugs, vaccines, contract research & manufacturing, biosimilars, and biologics are some of the major segments of the Indian pharma industry. India has highest number of pharmaceutical manufacturing facilities that comply with the US Food and Drug Administration (USFDA) and has 500 API producers that make for around 8% of the worldwide API market . The Indian cosmetics sector is currently going through a phase of tremendous expansion. The market for cosmetics in India was estimated to be worth US$ 11.6 billion in 2017 and is projected to expand at a CAGR of 15-20% from 2017 to 2025. The Indian cosmetics sector is expanding for a variety of reasons. The rise of the cosmetic sector has been fuelled by rising purchasing power, rising image consciousness among Indians, and the embrace of Western culture and lifestyle. Since ancient times, India has had an extensive record and a rich tradition of cosmetics. It is currently a thriving sector, and in the upcoming years, it is anticipated to surpass all other countries in terms of cosmetic consumption.

Our Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynaecological concerns, analgesics, fungal infections, and multivitamins. We also offer products for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums. All our products adhere to the rigorous standards of the pharmaceutical and cosmetics industries. Additionally, we are involved in the trading of certain packing materials and raw materials used in pharmaceutical and cosmetic products.

Strengths

Risk

Strategy